Second Sight Medical Products reported a net loss of $8.4 million, or $0.07 per share, for the second quarter of 2019 compared with a net loss of $8 million, or $0.12 per share, for the same time period a year ago, according to a press release.
Research and development expense increased to $3.4 million compared with $2.4 million in the second quarter of 2018.
Selling and marketing expense decreased to $1.7 million compared with $2.9 million a year ago, which was attributed to the decreased use of outside services, reduced (Read more...)
Uncategorized